Every year, hundreds of thousands of Americans are diagnosed with Lyme disease, according to the Centers for Disease Control and Prevention (CDC). With symptoms ranging from rashes and stiffness to ...

This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. While ...

Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the ...

Pfizer has announced that its new Lyme disease vaccine reduced the rate of infection by more than 70 percent in a recent trial. This is a notable achievement as an estimated 476,000 Americans contract ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies done on the vaccine. "What ...

THE FIGHT AGAINST LYME DISEASE WITH TICK SEASON NOW UPON US IN THE NORTHEAST, ACCORDING TO THE CDC, NEARLY HALF A MILLION AMERICANS ARE DIAGNOSED WITH LYME DISEASE EVERY YEAR. THERE IS NO VACCINE TO ...

GRAND RAPIDS, Mich — There is a concerning trend as we head into spring. The number of ticks and tick-borne illnesses is increasing. From 2016 to 2020 in Kent County, there were only about 11 cases of ...